Table 1.
Demographics and clinical characteristics of the sample.
| TD (n = 97) |
IP (n = 136) |
Statistic (χ2 or t-value) |
|
|---|---|---|---|
| Demographics | |||
| Age (M, SD) | 19.26 (4.56) | 18.64 (4.47) | −1.03 |
| Sex (% female) | 58.8% | 65.4% | 0.38 |
| Race/Ethnicity | |||
| Caucasian | 58.7% | 59.6% | 0.18 |
| American Indian/Alaskan Native | 0% | 0.7% | 0.89 |
| African American | 8.2% | 11.0% | 0.64 |
| Asian | 18.6% | 5.1% | 10.99* |
| Other/Biracial | 11.3% | 21.3% | 4.04 |
| Hispanic | 10.4% | 19.8% | 3.83 |
| Diagnoses | |||
| Current Anxiety Disorder | 0.0% | 72.1% | - |
| Current MDD | 0.0% | 29.4% | - |
| Past MDD | 0.0% | 47.8% | - |
| Comorbid Anxiety/Depression History | 0.0% | 49.3% | - |
| Clinical Characteristics (M, SD) | |||
| Depressive Symptoms (Z Score) | −1.02 (0.41) | 0.45 (1.43) | 9.82** |
| Anxiety Symptoms (Z Score) | −0.51 (0.71) | 0.46 (1.06) | 7.87** |
| Study Characteristics | |||
| Study Site (% UIC) | 73.2% | 71.3% | 0.75 |
Note. TD = typically developing; IP = internalizing psychopathology; MDD = major depressive disorder;
*
p < .01;
**
p < .001.